PlantPharm BioMed
Developer of a plant-based platform for production and oral delivery of vaccines and biopharmaceuticals. The platform uses genetically stable, clonal propagation in plants to express vaccine antigens and other therapeutic proteins, enabling shelf-stable oral solid dose formulations (tablets, capsules) for humans and pelletized feed for animals. The organization has supported this approach with >30 years of R&D, field testing and a double-blind human clinical trial of an oral Hepatitis B vaccine, and is engaged in government-collaborative projects for animal vaccine development.
Industries
Nr. of Employees
small (1-50)
PlantPharm BioMed
P.O. Box 569, Delavan, Wisconsin 53115, USA
Products
Oral solid dose Hepatitis B vaccine (clinical lot)
A plant-produced oral solid dose formulation of Hepatitis B vaccine evaluated in a double-blind human clinical trial and reported to be equivalent to standard comparators.
Oral solid dose Hepatitis B vaccine (clinical lot)
A plant-produced oral solid dose formulation of Hepatitis B vaccine evaluated in a double-blind human clinical trial and reported to be equivalent to standard comparators.
Services
Collaborative service to convert existing injectable vaccines and biopharmaceuticals into plant-produced oral solid dose or pelletized feed formats for expanded market access.
Development and production of pelletized feed vaccines and bait-station delivery systems for wildlife and farmed animals.
Execution of government-funded research projects for development of animal vaccine products and participation in One Health initiatives.
Collaborative service to convert existing injectable vaccines and biopharmaceuticals into plant-produced oral solid dose or pelletized feed formats for expanded market access.
Development and production of pelletized feed vaccines and bait-station delivery systems for wildlife and farmed animals.
Execution of government-funded research projects for development of animal vaccine products and participation in One Health initiatives.
Expertise Areas
- Plant-based vaccine production
- Oral solid dose vaccine formulation
- Animal vaccine delivery via feed
- Mucosal immunization strategies
Key Technologies
- Plant molecular expression systems
- Clonal plant propagation
- Oral solid dose (OSD) formulation
- Pelletized feed vaccine delivery
News & Updates
Presentation at World Vaccine Congress (April 22-24, 2025) discussing development of a pelletized feed vaccine for COVID-19 in animals.
Announcement of presentation on plant-based SARS-CoV-2 vaccine research at an international One Health symposium.
Press article (BizTimes) summarizing the company's efforts to develop plant-based edible vaccines (external media coverage referenced on site).
Award of more than $900,000 from the U.S. Department of Agriculture Animal and Plant Health Inspection Service to develop a feed-delivered SARS-CoV-2 vaccine for animals.
Growth of a plant crop containing Hepatitis B vaccine antigen and completion of an FDA-authorized double-blind human clinical trial demonstrating equivalence to standard Hepatitis B vaccines.
Presentation at World Vaccine Congress (April 22-24, 2025) discussing development of a pelletized feed vaccine for COVID-19 in animals.
Announcement of presentation on plant-based SARS-CoV-2 vaccine research at an international One Health symposium.
Press article (BizTimes) summarizing the company's efforts to develop plant-based edible vaccines (external media coverage referenced on site).
Award of more than $900,000 from the U.S. Department of Agriculture Animal and Plant Health Inspection Service to develop a feed-delivered SARS-CoV-2 vaccine for animals.
Growth of a plant crop containing Hepatitis B vaccine antigen and completion of an FDA-authorized double-blind human clinical trial demonstrating equivalence to standard Hepatitis B vaccines.